Finance And Related Services Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Paliperidone (Exclusively 1-Month Depot), Atc N05ax13 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V I. V. M. Paragraph 31 Paragraph 1 Sgb V on Blood Sugar Test Strips, for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Tildrakizumab, Atc L04ac17 for the Period January 1St, 2024 - December 31St, 2025

Medicines with the Active Ingredient Combination Timolol and Tafluprost (Atc: S01ed70)

Medicines with the Active Ingredient Distigmine (Atc: N07aa03)

Medicines Called Dysport(R) (Atc: M03ax21)

Medicines with the Active Ingredient Raltegravir (Atc: J05aj01)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Dimethyl Fumarate, Atc D05bx01 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Buserelin, Atc L02ae01 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Insulin Lispro, Atc A10ab04, A10ad04 F. D. Time 01/01/24 - 12/31/24 (Plus Extension Option 1X12 Months)